29 employees
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
2019
$110M
from 4 investors over 4 rounds
Sionna Therapeutics raised $110M on April 19, 2022
Investors: OrbiMed Advisors, RA Capital Management, L.P., Atlas Venture and T. Rowe Price